38 results
10-K
2023 FY
EX-4.2
ALT
Altimmune Inc
Annual report
27 Mar 24
4:03pm
S-3ASR
EX-4.5
ALT
Altimmune Inc
28 Feb 23
Automatic shelf registration
4:50pm
S-3ASR
EX-4.4
ALT
Altimmune Inc
28 Feb 23
Automatic shelf registration
4:50pm
10-K
2022 FY
EX-4.10
ALT
Altimmune Inc
Annual report
28 Feb 23
12:00am
10-K
2021 FY
EX-4.10
ALT
Altimmune Inc
Annual report
15 Mar 22
4:06pm
8-K
EX-4.1
t2xz44b
25 Feb 21
Enrollment in the Phase 1 AdCOVID™ Clinical Trial has Commenced
7:06am
8-K
EX-4.1
q8ft07qo5jwi916g qz
16 Jul 20
Altimmune Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
4:38pm
8-K
EX-4.2
384xsrj9sbsz
11 Mar 19
Altimmune Announces $14 million Registered Direct Offering
8:45am
8-K
EX-4.1
57teti9t
11 Mar 19
Altimmune Announces $14 million Registered Direct Offering
8:45am
8-K
EX-4.1
qqcv 9v52
9 Oct 18
Altimmune Announces $25 million Registered Direct Offering
9:14am
8-K
EX-4.2
gajkc verrlplp
9 Oct 18
Altimmune Announces $25 million Registered Direct Offering
9:14am
POS EX
EX-4.4
pdxrnf
28 Sep 18
Additional exhibits for listing
7:50am
POS EX
EX-4.3
wuzj3dkn
28 Sep 18
Additional exhibits for listing
7:50am